Emerging Markets Regulatory Tracker: Brazil (Vol. 4 No. 5)
This article was originally published in PharmAsia News
Executive Summary
Brazil’s Ministry of Health will reclassify “similar medicines” by the end of 2014 to align generic drug standards.